CCNO

CCNO (cyclin O) is a regulator of motile multiciliogenesis that acts in the apical cytoplasm of multiciliated cells downstream of multicilin to drive massive centriole amplification (PMID:24747639). Mechanistically, CCNO is required for the generation of deuterosomes — the principal platform for de novo centriole amplification in multiciliated cells — such that its loss restricts the number of mature centrioles that become ciliary basal bodies and thereby caps the number of motile cilia formed; the residual cilia that do form retain normal axonemal architecture and motility (PMID:24747639, PMID:25712475). Recessive loss-of-function CCNO mutations cause primary ciliary dyskinesia characterized by drastically reduced numbers of multiple motile cilia, with clinical features including hydrocephalus and female infertility that track with CCNO expression in respiratory, ependymal, and fallopian tube epithelia (PMID:24747639, PMID:26777464). In non-ciliated cancer contexts, CCNO functions as a pro-survival, pro-proliferative factor: it promotes cell-cycle entry and suppresses apoptosis, and is held in check by miR-302b/c/d-3p acting downstream of RACK1 (PMID:32792866, PMID:30464498).

1. 2014 High

   Established CCNO as a gene required for amplifying mother centrioles in multiciliated cells, answering why a subset of ciliopathy patients have too few cilia rather than dysmotile ones.

   Evidence Whole-exome sequencing of patients with reduced multiple motile cilia, subcellular analysis of mutant respiratory epithelium, and morpholino knockdown of the Xenopus ortholog

   PMID:24747639

   Open questions at the time

   • Molecular activity of CCNO (whether it functions as a canonical cyclin partner of a CDK) not defined
   • Direct biochemical partners at the centriole amplification machinery not identified
   • Position relative to multicilin established as downstream but intermediate steps unmapped
2. 2015 High

   Pinpointed the cellular step CCNO controls by showing it is required for deuterosome formation, identifying CCNO as the first known regulator of the deuterosome-based centriole amplification platform.

   Evidence Conditional Ccno knockout in mouse with immunofluorescence/EM quantification of deuterosomes and centrioles plus functional readouts (hydrocephalus, mucociliary clearance)

   PMID:25712475

   Open questions at the time

   • Molecular mechanism by which CCNO promotes deuterosome assembly unknown
   • No identified protein substrates or enzymatic complex linking CCNO to deuterosome biogenesis
   • Whether CCNO acts catalytically or as a scaffold not resolved
3. 2016 Medium

   Validated the pathogenicity of a specific missense variant and mapped CCNO expression to ependymal and fallopian tube epithelia, connecting genotype to the hydrocephalus and infertility phenotypes.

   Evidence Functional testing of the p.Leu213Pro variant in Xenopus, immunohistochemistry in mouse tissues, and clinical cohort analysis

   PMID:26777464

   Open questions at the time

   • Structural/biochemical basis for how p.Leu213Pro disrupts CCNO function not determined
   • Mechanistic link between CCNO loss and tissue-specific phenotype penetrance not explained
4. 2018 Medium

   Extended CCNO function beyond ciliogenesis by showing it promotes cancer cell survival and proliferation, raising the question of how a multiciliogenesis factor acts as a pro-survival cyclin.

   Evidence Lentiviral shRNA knockdown in gastric cancer lines with apoptosis (Caspase 3/7, flow cytometry), proliferation (MTT), xenograft, and microarray readouts

   PMID:30464498

   Open questions at the time

   • Direct molecular targets mediating the pro-survival effect not identified
   • Single-lab knockdown phenotype without reciprocal overexpression in same model
   • Relationship between this cell-cycle role and the centriole amplification role unclear
5. 2020 Medium

   Placed CCNO within a defined regulatory circuit by identifying it as a direct miR-302b/c/d-3p target downstream of RACK1, explaining one mechanism controlling its pro-proliferative output.

   Evidence Dual luciferase 3'UTR reporter, flow cytometry, EdU and TUNEL assays, and xenograft in cervical squamous carcinoma cells

   PMID:32792866

   Open questions at the time

   • Downstream effectors of CCNO driving cell-cycle entry not defined
   • Whether the RACK1/miR-302/CCNO axis operates outside cervical carcinoma unknown
   • No CDK or cyclin-partner biochemistry connecting CCNO to cell-cycle machinery

• The biochemical activity of CCNO — whether it functions as a true cyclin partnering a CDK, and the molecular link bridging its centriole-amplification role to its pro-survival role — remains unresolved.
• No identified CDK partner or kinase substrate in the corpus
• No structural model of CCNO
• Mechanism connecting deuterosome biogenesis function to cancer cell-cycle function not established